INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 222 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $42,000 | -61.1% | 24,515 | +13.6% | 0.00% | -75.0% |
| Q4 2021 | $108,000 | +83.1% | 21,587 | +160.2% | 0.00% | +100.0% |
| Q3 2021 | $59,000 | +96.7% | 8,297 | +157.9% | 0.00% | +100.0% |
| Q1 2021 | $30,000 | +76.5% | 3,217 | +69.0% | 0.00% | 0.0% |
| Q4 2020 | $17,000 | +750.0% | 1,903 | +1012.9% | 0.00% | – |
| Q3 2020 | $2,000 | -94.6% | 171 | -98.5% | 0.00% | -100.0% |
| Q4 2019 | $37,000 | +208.3% | 11,220 | +167.6% | 0.01% | +200.0% |
| Q2 2019 | $12,000 | +1100.0% | 4,193 | +1557.3% | 0.00% | +200.0% |
| Q1 2018 | $1,000 | – | 253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |